v3.26.1
Condensed Statements of Changes in Shareholders’ Equity (Deficit) (Unaudited) - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Feb. 08, 2026
Balance (in Shares) at Feb. 08, 2026      
Issuance of Class B ordinary shares [1] $ 843 24,157 25,000
Issuance of Class B ordinary shares (in Shares) [1]   8,433,333      
Net income (loss) (24,713) (24,713)
Balance at Mar. 31, 2026 $ 843 24,157 (24,713) 287
Balance (in Shares) at Mar. 31, 2026 8,433,333      
Balance at Feb. 08, 2026
Balance (in Shares) at Feb. 08, 2026      
Net income (loss)         986,279
Balance at Jun. 30, 2026 $ 19 $ 843 (6,776,614) (6,775,752)
Balance (in Shares) at Jun. 30, 2026 189,750 8,433,333      
Balance at Mar. 31, 2026 $ 843 24,157 (24,713) 287
Balance (in Shares) at Mar. 31, 2026 8,433,333      
Accretion for Class A ordinary shares to redemption amount (9,984,720) (7,762,893) (17,747,613)
Sale of Private Placement Warrants 5,000,000 5,000,000
Fair value of Public Warrants at issuance 3,542,000 3,542,000
Fair value of representative shares deferred until IPO $ 19 1,626,881 1,626,900
Fair value of representative shares deferred until IPO (in Shares) 189,750      
Allocated value of transaction costs to Class A shares (208,318) (208,318)
Net income (loss) 1,010,992 1,010,992
Balance at Jun. 30, 2026 $ 19 $ 843 $ (6,776,614) $ (6,775,752)
Balance (in Shares) at Jun. 30, 2026 189,750 8,433,333      
[1] Includes up to 1,100,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On June 12, 2026, the underwriters closed their over-allotment option in full subsequent to the closing of the Initial Public Offering. As a result of the underwriters’ election to fully exercise their over-allotment option, 1,100,000 Founder Shares were no longer subject to forfeiture by the Sponsor (see Note 7).